These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2821720)

  • 1. Vasoactive intestinal polypeptide enhances ACTH levels in some patients with adrenocorticotropin-secreting pituitary adenomas.
    Ambrosi B; Bochicchio D; Sartorio A; Morabito F; Faglia G
    Acta Endocrinol (Copenh); 1987 Oct; 116(2):216-20. PubMed ID: 2821720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Corticotropin-releasing hormone (CRH) stimulation in Nelson's syndrome: response of adrenocorticotropin secretion to pulse injection and continuous infusion of CRH.
    Oldfield EH; Schulte HM; Chrousos GP; Gold PW; Benker G; Peterson RE; Cutler GB; Loriaux DL
    J Clin Endocrinol Metab; 1986 May; 62(5):1020-6. PubMed ID: 3007552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Usefulness of the desmopressin test in the postoperative evaluation of patients with Cushing's disease.
    Colombo P; Dall'Asta C; Barbetta L; Re T; Passini E; Faglia G; Ambrosi B
    Eur J Endocrinol; 2000 Aug; 143(2):227-34. PubMed ID: 10913942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stimulation by peptide histidine methionine (PHM) of adrenocorticotropin secretion in patients with Cushing's disease: a comparison with the effect of vasoactive intestinal peptide (VIP) and a study on the effect of combined administration of corticotropin-releasing hormone with PHM or VIP.
    Watanobe H; Tamura T
    J Clin Endocrinol Metab; 1994 Jun; 78(6):1372-7. PubMed ID: 8200939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma ACTH and cortisol responses to TRF, vasopressin or hypoglycemia in cushing's disease and nelson's syndrome.
    Krieger DT; Luria M
    J Clin Endocrinol Metab; 1977 Feb; 44(2):361-8. PubMed ID: 190254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. VIP stimulates ACTH release and adenylate cyclase in human ACTH-secreting pituitary adenomas.
    Oliva D; Nicosia S; Spada A; Giannattasio G
    Eur J Pharmacol; 1982 Sep; 83(1-2):101-5. PubMed ID: 6290240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adrenocorticotropin levels do not change during early recovery of transsphenoidal surgery for ACTH-secreting pituitary tumors.
    Pimentel-Filho FR; Cukiert A; Miyashita F; Huayllas MK; Knoepfelmacher M; Salgado LR; Liberman B
    J Endocrinol Invest; 2001 Feb; 24(2):83-7. PubMed ID: 11263476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electron microscopical morphometry of well-differentiated and undifferentiated ACTH secreting adenomas in Cushing's disease and Nelson's syndrome.
    Reuss WA; Saeger W; Lüdecke DK
    Virchows Arch A Pathol Anat Histopathol; 1991; 419(5):395-401. PubMed ID: 1661044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A suppressive effect of dexamethasone (DEX) on adrenocorticotropin (ACTH) response to vasoactive intestinal peptide (VIP) in Cushing's disease: a parallel modulation by DEX of ACTH responses to VIP and corticotropin-releasing hormone.
    Watanobe H; Tamura T
    Neuropeptides; 1997 Feb; 31(1):35-40. PubMed ID: 9574835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolactin secretion by mixed ACTH-prolactin pituitary adenoma cells in culture.
    Yamaji T; Ishibashi M; Teramoto A; Fukushima T
    Acta Endocrinol (Copenh); 1985 Apr; 108(4):456-63. PubMed ID: 2859725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High prolactin levels in patients with Cushing's disease without pathological evidence of pituitary adenoma.
    Comtois R; Beauregard H; Hardy J; Robert F; Somma M
    Clin Endocrinol (Oxf); 1993 Jun; 38(6):601-7. PubMed ID: 8392915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperprolactinemia in Cushing's disease and Nelson's syndrome.
    Yamaji T; Ishibashi M; Teramoto A; Fukushima T
    J Clin Endocrinol Metab; 1984 May; 58(5):790-5. PubMed ID: 6323516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of synthetic corticotropin-releasing factor in normal individuals and in patients with hypothalamic-pituitary-adrenocortical disorders.
    Jørgensen H; Skare S; Frey H; Hanssen KF; Norman N
    Acta Med Scand; 1985; 218(1):79-84. PubMed ID: 2996312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A study of patients with Nelson's syndrome.
    Pereira MA; Halpern A; Salgado LR; Mendonça BB; Nery M; Liberman B; Streeten DH; Wajchenberg BL
    Clin Endocrinol (Oxf); 1998 Oct; 49(4):533-9. PubMed ID: 9876353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A correlative study between cortisol and ACTH in Cushing's disease following bilateral adrenalectomy and in Nelson's syndrome.
    Kasperlik-Załuska A; Niegowska E; Migdalska B; Jeske W; Zieliński M
    Endokrynol Pol; 1992; 43(3):314-21. PubMed ID: 1345571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gel chromatographic characterization of immunoreactive adrenocorticotropin in patients with ACTH hypersecretion.
    Reincke M; Allolio B; Deuss U; Winkelmann W
    Klin Wochenschr; 1989 Nov; 67(21):1096-100. PubMed ID: 2555628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Profound amplification of secretory-burst mass and anomalous regularity of ACTH secretory process in patients with Nelson's syndrome compared with Cushing's disease.
    van Aken MO; Pereira AM; van den Berg G; Romijn JA; Veldhuis JD; Roelfsema F
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):765-72. PubMed ID: 15163342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Is it possible to predict the development of Nelson's syndrome in Cushing's disease after bilateral adrenalectomy?].
    Horký K; Kanka J; Gregorová I; Tomsová Z; Dvoráková J
    Cas Lek Cesk; 1990 May; 129(21):645-9. PubMed ID: 2164450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of metyrapone pretreatment on adrenocorticotropin secretion induced by corticotropin-releasing hormone in normal subjects and patients with Cushing's disease.
    Totani Y; Niinomi M; Takatsuki K; Oiso Y; Tomita A
    J Clin Endocrinol Metab; 1990 Mar; 70(3):798-803. PubMed ID: 2155255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of ACTH secretion in Cushing's adenoma and clinically silent corticotroph adenoma by cell immunoblot assay.
    Kojima Y; Suzuki S; Yamamura K; Ohhashi G; Yamamoto I
    Endocr J; 2002 Jun; 49(3):285-92. PubMed ID: 12201210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.